Hospital investors lead oversubscribed financing

医院投资者领衔超额认购融资

DURHAM, N.C.

北卡罗来纳州达勒姆

,

，

July 14, 2026

2026年7月14日

/PRNewswire/ -- 410 Medical, Inc., a medical device company focused on innovative technologies for emergency and critical care, today announced the completion of a $12 million financing round. Orlando Health Ventures led the round, with participation from Hatteras Venture Partners, Ballad Health, OSF Healthcare, Rex Health Ventures, CU Healthcare Innovations Fund, Sarnova, Catalyst by Wellstar, Tampa General, and a new undisclosed strategic investor..

/美通社/ -- 专注于急诊和重症监护创新技术的医疗设备公司410 Medical, Inc.今日宣布完成一轮1200万美元的融资。本轮融资由Orlando Health Ventures领投，Hatteras Venture Partners、Ballad Health、OSF Healthcare、Rex Health Ventures、CU Healthcare Innovations Fund、Sarnova、Catalyst by Wellstar、Tampa General以及一家新的未披露战略投资者参与投资。

The new funding will be used to scale 410 Medical's commercial operations and support the launch of LifeFlow's next-generation infuser.

新资金将用于扩大410 Medical的商业运营，并支持LifeFlow下一代输液泵的发布。

'The heightened interest in this round reflects the confidence investors and customers have in 410 Medical's mission and products,' said Kyle Chenet, Chief Executive Officer at 410 Medical. 'With this funding, we're able to expand our commercial reach, bringing LifeFlow to more clinicians and investing in the next generation of our technology.

“本轮融资中激增的关注度反映了投资者和客户对410 Medical的使命和产品的信心。” 410 Medical首席执行官Kyle Chenet表示。“通过这笔资金，我们能够扩大商业覆盖范围，将LifeFlow带给更多的临床医生，并投资于下一代技术的研发。

We're grateful to Orlando Health Ventures for leading this round and excited to welcome Tampa General and an additional strategic partner to our syndicate.'.

我们感谢奥兰多健康风险投资公司领投本轮融资，并很高兴地欢迎坦帕总医院以及另一家战略合作伙伴加入我们的投资联盟。

Backing Continued Commercial Growth

支持持续的商业增长

410 Medical's LifeFlow products are used by more than 500 hospitals and EMS agencies across the country to help clinicians deliver fluid and blood quickly and effectively for patients experiencing sepsis, hemorrhagic shock, and other life-threatening conditions. Nearly 80,000 patients have been treated using LifeFlow.

410 Medical 的 LifeFlow 产品被全国 500 多家医院和急救医疗服务机构采用，帮助临床医生为患有脓毒症、失血性休克及其他危及生命的患者快速有效地输注液体和血液。已有近 80,000 名患者接受过 LifeFlow 治疗。

This financing enables the company to accelerate LifeFlow adoption and reach into new hospital systems and EMS agencies nationwide..

这笔融资使公司能够加速LifeFlow的采用，并拓展至全国范围内的新医院系统和紧急医疗服务机构。

'Orlando Health Ventures is proud to lead this round and deepen our partnership with 410 Medical,' said Bobby Helmedag, Managing Director of Orlando Health Ventures. 'LifeFlow addresses a critical gap in resuscitative care, and we've seen firsthand the impact it can have for clinicians and patients.

“奥兰多健康风投很荣幸能领投本轮融资，并深化我们与410 Medical的合作伙伴关系，”奥兰多健康风投董事总经理鲍比·赫尔梅达格表示。“LifeFlow填补了复苏救治领域的一个关键空白，我们已亲眼目睹它为临床医生和患者带来的影响。”

We're excited to support the team as they scale commercial operations and advance the next generation of the LifeFlow infuser.'.

我们很高兴支持该团队扩大商业运营，并推进下一代 LifeFlow 输液泵的研发。

Investing in the Next Generation of LifeFlow

投资下一代 LifeFlow

Alongside its commercial expansion, 410 Medical is investing in the future expansion of LifeFlow technologies. The next-generation device, planned for launch in 2027, builds on feedback from nearly ten years of experience partnering with front-line medical providers working tirelessly to provide effective resuscitation for critically ill patients.

在进行商业扩张的同时，410 Medical 公司也在投资 LifeFlow 技术的未来拓展。计划于 2027 年推出的下一代设备，基于近十年来与一线医疗提供者合作的经验反馈，这些医疗人员不懈努力，为危重病人提供有效的复苏治疗。

Speed, portability and ease of use are essential in these moments. The new LifeFlow technology will address these and other unmet needs. .

在这些时刻，速度、便携性和易用性至关重要。全新的LifeFlow技术将满足这些及其他尚未被满足的需求。

About 410 Medical, Inc.

关于410医疗公司

Founded in 2013, 410 Medical is a North Carolina-based medical device company focused on advanced resuscitation technologies to improve the care of critically ill patients. Our lead product LifeFlow

410 Medical 成立于2013年，是一家位于北卡罗来纳州的医疗设备公司，专注于先进复苏技术，以改善危重患者的护理。我们的主打产品 LifeFlow

®

®

received FDA clearance in 2016 and is used to enhance the administration of fluid and blood products for patients with sepsis, hemorrhagic shock, and other life-threatening conditions. 410 Medical is committed to providing innovative technologies, education, and support for emergency and critical care providers to deliver effective resuscitation when minutes matter..

于2016年获得美国食品药品监督管理局（FDA）许可，用于优化脓毒症、失血性休克及其他危及生命状况患者的液体和血液制品输注。410 Medical致力于提供创新技术、教育和支持，帮助急诊和重症监护医护人员在分秒必争的关键时刻实施有效复苏。

For more information visit

更多信息请访问

www.410medical.com

www.410medical.com

Media Contact:

媒体联系人：

Carla Hoffman

卡拉·霍夫曼

[email protected]

[email protected]

SOURCE 410 Medical, Inc.

SOURCE 410 医疗公司

21

二十一

%

百分比

more press release views with

更多新闻稿浏览量，借助

Request a Demo

申请演示